James L. Gulley, MD, PhD, FACP, National Cancer Institute, explains Combining TGF-? & PD-L1 is Developing One Drug | Very Little Increased Cost in Side-Effects at Annual Meeting 2018
Combining TGF-? & PD-L1 is Developing One Drug | Very Little Increased Cost in Side-Effects
